Skip to content
★ Sign in to follow
MM

Melanie Meads

Executive
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€1,986
▼ Sales (0 ops.)
—

Latest filing published 31 Mar 2017 for BioPharma Credit PLC, €1,986.

Filing timeline

BuySale
Melanie Meads

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 31 Mar 2017 · 3510 days ago · €1,986
    +0.2%
    Entry US$1.03 · Close at T+365 US$1.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Melanie Meads: trading record in brief

Only one filing by Melanie Meads is known so far (31 March 2017): an open-market purchase, €1,986, in BioPharma Credit PLC. That is too little to draw conclusions. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to Melanie Meads

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)ExecutivesBioPharma Credit PLC
    1,702 GBP37FCA-NSM
    2,067 shares@ £0.8232100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BDGKMY29FCA-NSM:LSE20170331141504_13179325_20200330131526870_26612
    Canonical exit: 29 Jun 2017 (T+90)

1 of 1 declaration